Answers are grounded in this paper and cite their sources.
This study evaluated titers and amplitudes of anti-E2 antibodies (anti-E2-Abs) and neutralizing antibodies against hepatitis C virus (HCV; anti-HCV-nAbs) in HIV/HCV-coinfected individuals over five years after successful HCV treatment completion.
No takes yet. Share an insight, caveat, or question.
Sepúlveda‐Crespo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: